A recent BCG report on the biopharma industry projects that tirzepatide-based products will lead the industry in 2030 (Mounjaro and Zepbound total $56B). Eight of the ten best-selling biopharma products…
We provide custom solutions to all types of pharmaceutical development organizations.
